| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 1.41M | — |
| Operating expense | — | — |
| Net income | -7.16M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ABUS returned +45.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +8.3% |
| 1 year | +45.1% |
| 5 years | +51.9% |
| 10 years | +36.7% |
| All-time high | $25.61 (Jan 2015) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in ABUS would be worth today ›No. Arbutus Biopharma Corporation has not paid a dividend in the past 12 months.
Arbutus Biopharma Corporation stock trades on NASDAQ under the ticker symbol ABUS.
Arbutus Biopharma Corporation is part of the Healthcare sector.
Arbutus Biopharma Corporation has a market cap of 1.03B USD, based on the latest quote.
Arbutus Biopharma Corporation is expected to report earnings around Nov 16, 2026. That date is an estimate and has not been confirmed by the company.
